Skip to main content

Gallium Ga 68 Gozetotide Dosage

Applies to the following strengths: 25 mcg

Usual Adult Dose for Prostate Cancer

111 MBq to 259 MBq intravenously (3 mCi to 7 mCi) as a slow intravenous injection.

Calculate necessary volume to administer based on calibration time and required dose.
After drug administration, administer an intravenous flush of sterile 0.9% sodium chloride injection, USP.

Use: As a radioactive diagnostic agent for men with prostate cancer.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available




Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:
Administer as slow intravenous injection.
Use appropriate radiation shielding technique while withdrawing and administering the dose.
Initiate positron emission tomography (PET) scan 50 to 100 minutes after dose administration.
If necessary, a diuretic may be administered to decrease radiotracer accumulation in the urinary bladder and ureters.
After radiolabeling, use within 4 hours.

Storage requirements:
Before reconstitution, store at 2C to 25C (36F to 77F).
After radiolabeling, store upright below 30C (86F) with an appropriate lead shielding to protect from radiation.
Do not freeze.

Reconstitution/preparation techniques:
The manufacturer product information should be consulted.

This drug is for diagnostic use only.

Patient advice:
Stay well hydrated before dose administration.
Urinate immediately prior to image acquisition and frequently during first hours following administration to reduce radiation exposure.

More about gallium Ga 68 gozetotide

Professional resources

Other brands

Locametz, Illuccix

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.